| Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients: the ARISTOPHANES study GYH Lip, A Keshishian, X Li, M Hamilton, C Masseria, K Gupta, X Luo, ... Stroke 49 (12), 2933-2944, 2018 | 330 | 2018 |
| Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin GYH Lip, A Keshishian, S Kamble, X Pan, J Mardekian, R Horblyuk, ... Thrombosis and haemostasis 116 (11), 975-986, 2016 | 316 | 2016 |
| Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice X Li, S Deitelzweig, A Keshishian, M Hamilton, R Horblyuk, K Gupta, ... Thrombosis and haemostasis 117 (06), 1072-1082, 2017 | 185 | 2017 |
| Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared … A Amin, A Keshishian, J Trocio, O Dina, H Le, L Rosenblatt, X Liu, ... Current medical research and opinion 33 (9), 1595-1604, 2017 | 75 | 2017 |
| Comparisons between oral anticoagulants among older nonvalvular atrial fibrillation patients S Deitelzweig, A Keshishian, X Li, A Kang, AD Dhamane, X Luo, ... Journal of the American Geriatrics Society 67 (8), 1662-1671, 2019 | 58 | 2019 |
| Effectiveness and safety of apixaban versus warfarin as outpatient treatment of venous thromboembolism in US clinical practice D Weycker, X Li, GDV Wygant, T Lee, M Hamilton, X Luo, L Vo, ... Thrombosis and haemostasis 118 (11), 1951-1961, 2018 | 48 | 2018 |
| Examining the effect of medication adherence on risk of subsequent fracture among women with a fragility fracture in the US medicare population A Keshishian, N Boytsov, R Burge, K Krohn, L Lombard, X Zhang, L Xie, ... Journal of Managed Care & Specialty Pharmacy 23 (11), 1178-1190, 2017 | 48 | 2017 |
| Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study GYH Lip, AV Keshishian, AL Kang, AD Dhamane, X Luo, X Li, ... Journal of internal medicine 289 (1), 42-52, 2021 | 47 | 2021 |
| Real-world comparative effectiveness, safety, and health care costs of oral anticoagulants in nonvalvular atrial fibrillation patients in the US Department of Defense Population K Gupta, J Trocio, A Keshishian, Q Zhang, O Dina, J Mardekian, ... Journal of managed care & specialty pharmacy 24 (11), 1116-1127, 2018 | 42 | 2018 |
| Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: comparative effectiveness and safety evaluated using a … X Li, A Keshishian, M Hamilton, R Horblyuk, K Gupta, X Luo, J Mardekian, ... PLoS One 13 (1), e0191722, 2018 | 42 | 2018 |
| Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure A Amin, AB Garcia Reeves, X Li, A Dhamane, X Luo, M Di Fusco, ... PLoS One 14 (3), e0213614, 2019 | 38 | 2019 |
| Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients with active cancer S Deitelzweig, AV Keshishian, Y Zhang, A Kang, AD Dhamane, X Luo, ... Cardio Oncology 3 (3), 411-424, 2021 | 34 | 2021 |
| Effectiveness and safety of oral anticoagulants among NVAF patients with obesity: insights from the ARISTOPHANES study S Deitelzweig, A Keshishian, A Kang, AD Dhamane, X Luo, X Li, ... Journal of Clinical Medicine 9 (6), 1633, 2020 | 32 | 2020 |
| Oral anticoagulants for nonvalvular atrial fibrillation in patients with high risk of gastrointestinal bleeding GYH Lip, AV Keshishian, Y Zhang, A Kang, AD Dhamane, X Luo, C Klem, ... JAMA Network Open 4 (8), e2120064-e2120064, 2021 | 31 | 2021 |
| Effectiveness and safety of apixaban, low-molecular-weight heparin, and warfarin among venous thromboembolism patients with active cancer: a US claims data analysis A Cohen, A Keshishian, T Lee, G Wygant, L Rosenblatt, P Hlavacek, ... Thrombosis and Haemostasis 121 (03), 383-395, 2021 | 31 | 2021 |
| Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population K Gupta, J Trocio, A Keshishian, Q Zhang, O Dina, J Mardekian, ... BMC cardiovascular disorders 19, 1-10, 2019 | 27 | 2019 |
| Costs of relapsed diffuse large B-cell lymphoma among Medicare patients S Huntington, A Keshishian, M McGuire, L Xie, O Baser Leukemia & lymphoma 59 (12), 2880-2887, 2018 | 27 | 2018 |
| Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population A Keshishian, N Boytsov, R Burge, K Krohn, L Lombard, X Zhang, L Xie, ... Osteoporosis International 28, 2485-2494, 2017 | 27 | 2017 |
| Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients S Deitelzweig, A Keshishian, A Kang, AD Dhamane, X Luo, ... Therapeutic advances in gastroenterology 14, 1756284821997352, 2021 | 26 | 2021 |
| A real-world observational study of hospitalization and health care costs among nonvalvular atrial fibrillation patients prescribed oral anticoagulants in the US Medicare … A Amin, A Keshishian, J Trocio, O Dina, H Le, L Rosenblatt, X Liu, ... Journal of Managed Care & Specialty Pharmacy 24 (9), 911-920, 2018 | 26 | 2018 |
Onur Baser在 sph.cuny.edu 的电子邮件经过验证
